Rethinking internal quality control: the time is now
- PMID: 35766232
- DOI: 10.1515/cclm-2022-0587
Rethinking internal quality control: the time is now
Comment on
-
How to evaluate fixed clinical QC limits vs. risk-based SQC strategies.Clin Chem Lab Med. 2022 Jun 14;60(9):e199-e201. doi: 10.1515/cclm-2022-0539. Print 2022 Aug 26. Clin Chem Lab Med. 2022. PMID: 35694816 No abstract available.
References
-
- Westgard, JO, Bayat, H, Westgard, SA. How to evaluate fixed clinical QC limits vs. risk-based SQC strategies. Clin Chem Lab Med 2022;60:e199–201. https://doi.org/10.1515/cclm-2022-0539.
-
- Panteghini, M. Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement. Clin Chem Lab Med 2010;48:7–10. https://doi.org/10.1515/CCLM.2010.020.
-
- Braga, F, Pasqualetti, S, Aloisio, E, Panteghini, M. The internal quality control in the traceability era. Clin Chem Lab Med 2020;59:291–300. https://doi.org/10.1515/cclm-2020-0371.
-
- Panteghini, M, Sandberg, S. Defining analytical performance specifications 15 years after the Stockholm conference. Clin Chem Lab Med 2015;53:829–32. https://doi.org/10.1515/cclm-2015-0303.
-
- Panteghini, M. et al..: keep your eyes wide … as the present now will later be the past. Clin Chem Lab Med 2022;60:e202–3. https://doi.org/10.1515/cclm-2022-0557.
Publication types
LinkOut - more resources
Full Text Sources